Drug Pipeline

Tebentafusp Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
8
Recruiting
2
Phase 3
8
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
6
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05549297 Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma… Advanced Melanoma Recruiting
NCT06246149 Adjuvant Tebentafusp in High Risk Ocular Melanoma Uveal Melanoma Recruiting
Phase 2
NCT06942442 A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell… HLA-A*0201 Positive Cells Present Recruiting
NCT06627244 Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma Metastatic Uveal Melanoma Recruiting
NCT06070012 Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma Uveal Melanoma Recruiting
NCT07057596 Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma Mestastatic Uveal Melanoma Recruiting
NCT07276386 Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal… Metastatic Uveal Melanoma Recruiting
NCT06414590 Neoadjuvant Tebentafusp for Uveal Melanoma Locally Advanced Unresectable Uveal Melanoma Recruiting
Sponsors Running Tebentafusp Trials
Immunocore Ltd (1) Diwakar Davar (1) European Organisation for Research and Treatment of Cancer - EORTC (1) Thomas Jefferson University (1) University of Miami (1) Sarcoma Alliance for Research through Collaboration (1) Grupo Español Multidisciplinar de Melanoma (1) H. Lee Moffitt Cancer Center and Research Institute (1)
Disease Areas
Melanoma (7) Sarcoma (1)
Get alerts when Tebentafusp trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free